SAM
MRNA icon

Storebrand Asset Management’s Moderna MRNA Stock Holding History

Storebrand Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-350
Closed -$10.3K – 784
2025
Q4 		$10.3K Sell
350
-1,087
-76% -$29.5K ﹤0.01% 769
2025
Q3 		$37.1K Sell
1,437
-5,894
-80% -$164K ﹤0.01% 773
2025
Q2 		$202K Sell
7,331
-19,599
-73% -$516K ﹤0.01% 730
2025
Q1 		$763K Sell
26,930
-16,961
-39% -$602K ﹤0.01% 672
2024
Q4 		$1.82M Sell
43,891
-48,048
-52% -$2.3M 0.01% 608
2024
Q3 		$6.14M Buy
91,939
+7,173
+8% +$659K 0.02% 479
2024
Q2 		$10.1M Sell
84,766
-4,645
-5% -$588K 0.03% 382
2024
Q1 		$9.53M Sell
89,411
-15,371
-15% -$1.55M 0.03% 394
2023
Q4 		$10.4M Buy
104,782
+5,349
+5% +$450K 0.04% 375
2023
Q3 		$10.3M Sell
99,433
-47,097
-32% -$5.25M 0.05% 354
2023
Q2 		$17.8M Sell
146,530
-8,423
-5% -$1.12M 0.08% 275
2023
Q1 		$23.8M Buy
154,953
+7,898
+5% +$1.3M 0.12% 207
2022
Q4 		$26.4M Buy
147,055
+633
+0.4% +$104K 0.15% 188
2022
Q3 		$17.3M Sell
146,422
-4,036
-3% -$612K 0.1% 231
2022
Q2 		$21.5M Buy
150,458
+1,928
+1% +$276K 0.12% 211
2022
Q1 		$25.6M Sell
148,530
-10,685
-7% -$1.8M 0.12% 202
2021
Q4 		$40.4M Buy
159,215
+15,545
+11% +$4.55M 0.18% 137
2021
Q3 		$55.3M Buy
143,670
+5,659
+4% +$2.09M 0.27% 83
2021
Q2 		$32.4M Sell
138,011
-8,740
-6% -$1.56M 0.16% 154
2021
Q1 		$19.2M Buy
146,751
+3,909
+3% +$566K 0.1% 241
2020
Q4 		$14.9M Buy
142,842
+45,466
+47% +$4.6M 0.09% 268
2020
Q3 		$6.89M Buy
97,376
+24,666
+34% +$1.72M 0.05% 352
2020
Q2 		$4.67M Buy
+72,710
New +$3.98M 0.04% 402

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Storebrand Asset Management's MRNA Position: Q1 2026 in Review

Storebrand Asset Management sold out of Moderna (MRNA) in Q1 2026, closing a stake of 350 shares — an estimated $10.3K sold.

Storebrand Asset Management first reported a position in MRNA in Q2 2020 and held it in 23 quarters. The position peaked at $55.3M in Q3 2021. 726 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Storebrand Asset Management reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Storebrand Asset Management sold 350 Moderna shares in Q1 2026, an estimated $10.3K.
  • Storebrand Asset Management first reported a position in Moderna in Q2 2020 and held it in 23 quarters.
  • Storebrand Asset Management's Moderna position peaked at $55.3M in Q3 2021.
  • 726 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Storebrand Asset Management's 13F filing for Q1 2026, filed 5 May 2026.